Subgroup analysis – Political affiliation. by Mehdi Mourali (10170245)

“…This approach, known as “equal treatment,” aims to treat all individuals equally regardless of their demographic characteristics. …”

Sample scenario description. by Mehdi Mourali (10170245)

“…This approach, known as “equal treatment,” aims to treat all individuals equally regardless of their demographic characteristics. …”

AMCEs – Pooled across scenarios. by Mehdi Mourali (10170245)

“…This approach, known as “equal treatment,” aims to treat all individuals equally regardless of their demographic characteristics. …”

Methodological flowchart. by Mehdi Mourali (10170245)

“…This approach, known as “equal treatment,” aims to treat all individuals equally regardless of their demographic characteristics. …”

Preference for the EIA vs. ETA across scenarios. by Mehdi Mourali (10170245)

“…This approach, known as “equal treatment,” aims to treat all individuals equally regardless of their demographic characteristics. …”

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. by Tamjid A. Chowdhury (14149846)

Mean plasma concentration-time profiles of paeoniflorin and paeonol after single oral administration in NC and DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Subjects:

Baseline characteristics and oxidative profiling. by Summan Thahiem (20988319)

Subjects:

Effect of Viscosol on upstream mediators of inflammasomes activation, PTP1B and inflammasome complexes. by Summan Thahiem (20988319)

Subjects:

Co-transformed cells grow preferentially as tumors in peritoneal cavities. by Mitchell Hayes (5334887)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …”

Changes in the genotypes of <i>NLRP1</i>, <i>NLRP3</i>, and <i>NLRP4</i>. by Hao Deng (409186)

Subjects:

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

Subjects:

Effect of the interaction of drinking, smoking and <i>ERCC1</i> rs3212986 on workers exposed to coal dust. by Hao Deng (409186)

Subjects:

Regression model analysis of the influence of <i>ERCC1</i> rs3212986 on CWP. by Hao Deng (409186)

Subjects:

Pathways analysis of ERCC1 based on CWP metabolome and proteome. by Hao Deng (409186)

Subjects: